Patents by Inventor Peter Jungblut

Peter Jungblut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of specific differentially expressed antigens
    Patent number: 7772386
    Abstract: The present invention relates to compositions useful in immunization against pathogenic organisms of the genus Mycobacterium and for diagnostic purposes. In particular, the present invention relates to a composition comprising at least one protein which is differentially expressed in a virulent strain as compared to an avirulent strain of Mycobacteria. Furthermore, the invention relates to compositions comprising fusion proteins, antigenic fragments, nucleic acid molecules encoding the aforementioned proteinaceous compounds and/or antibodies thereto. Additionally, the invention relates to pharmaceutical and diagnostic compositions comprising or employing compounds of the invention. In addition, the present invention relates to the use of the compounds of the invention for the treatment of Mycobacterium induced diseases and/or for the preparation of a vaccine for vaccination against Mycobacterium induced diseases.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: August 10, 2010
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Peter Jungblut, Stefan H. E. Kaufmann, Ulrich Schaible, Hans Mollenkopf, Bärbel Raupach, Ursula Zimny-Arndt, Stephanie Lamer, Jens Mattow
  • Method for identifying helicobacter antigens
    Publication number: 20030180330
    Abstract: The present invention relates to a method for characterizing or identifying proteins which are expressed by cultivated Helicobacter cells and which preferably react with human antisera. Thus, novel Helicobacter antigens are provided which are suitable as targets for the diagnostis, prevention or treatment of Helicobacter infections.
    Type: Application
    Filed: April 29, 2003
    Publication date: September 25, 2003
    Inventors: Thomas F Meyer, Peter Jungblut, Dirk Baumann, Anton Aebischer, Gaby Haas, Ursula Zimny-Arndt, Stephanie Lamer, Galip Karaali, Nicolas Sabarth, Meike Wendland
  • Agents and method for diagnosing lyme disease and borreliosis vaccine
    Publication number: 20030138868
    Abstract: The invention relates to agents for diagnosing and/or treating Lyme disease which contain the antigens of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH), oligopeptide permease, oligopeptide ABC transporter periplasmic BP(oppA-2)(Bb), glycosyl transferase IgtD homologue, heat shock protein 90, VLSE fragment, (U76406) putative v1s rec. casette V1s6 Borrelia burgdorferi, flagellin protein Borrelia garinii, (AE001578) conserved hypothetical protein cp32-6 Borrelia burgdorferi, membrane assoc. protein p66 percursor Borrelia burgdoferii, oligopeptide ABC transporter periplasmic BP (oppA-4)(Bc), fructose-biphosphate aldose (fba) Borrelia burgdorferi, DNAK protein Heat Shock Protein 70 Borrelia burgdorferi, orfE Borrelia burgdorferi, outer surface protein B precursor Borrelia burgdorferi, L-lactate dehydrogenase (ldh), P83/100 gene Borrelia burgdorferi, enolase 2-phosphoglycerate Borrelia burgdorferi, flagellin Protein Borrelia garinii, hypothetical protein BBE28 Borrelia burgdorferi, DNA direct.
    Type: Application
    Filed: September 30, 2002
    Publication date: July 24, 2003
    Inventors: Peter Jungblut, Aydan DIlgimen, Sascha Thies, Brigitte Wittmann
  • 17-halomethylene estratrienes
    Patent number: 5124321
    Abstract: 17-halomethylene estratrienes of Formula I ##STR1## wherein R.sub.1 is hydrogen, a methyl or acyl group, andR.sub.2 is a halogen atom, show low affinity to the estrogen receptor and bring about a cellular membrane and blood/lymphatic vessel permeability that is increased as compared with estradiol.
    Type: Grant
    Filed: December 7, 1988
    Date of Patent: June 23, 1992
    Assignee: Schering Aktiengesellschaft
    Inventors: Peter Jungblut, Rudolf Wiechert, Rolf Bohlmann
  • 17-methylene- and 17-ethylidene-estratrienes
    Patent number: 4977147
    Abstract: A pharmaceutical preparation for treating menopausal symptoms, estrogen deficiency and hormone-dependent tumors, and for use as a contraceptive, comprises a compound of formula I ##STR1## wherein R.sub.1 is hydrogen, methyl, a tetrahydropyranyl group or an acyl group andR.sub.2 is hydrogen or methyl.
    Type: Grant
    Filed: December 7, 1988
    Date of Patent: December 11, 1990
    Assignee: Schering Aktiengesellschaft
    Inventors: Peter Jungblut, Rudolf Wiechert, Dieter Bittler